AMPK activators, mTOR suppressors, and trehalose have been demonstrated to be effective in animal models of neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and Huntington’s diseases. The gene discussed is PRKAA2; the disease is Huntington disease.